In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Seres Therapeutics Inc (NASDAQ: MCRB) closed the day trading at $0.69 down -3.51% from the previous closing price of $0.72. In other words, the price has decreased by -$3.51 from its previous closing price. On the day, 0.88 million shares were traded. MCRB stock price reached its highest trading level at $0.7518 during the session, while it also had its lowest trading level at $0.6779.
Ratios:
For a better understanding of MCRB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 3.91 whereas as Long-Term Debt/Eq ratio is at 3.56.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 18 ’25 when Young Teresa L. sold 3,338 shares for $0.81 per share. The transaction valued at 2,704 led to the insider holds 97,536 shares of the business.
Henn Matthew R. sold 3,953 shares of MCRB for $3,204 on Feb 18 ’25. The insider now owns 84,443 shares after completing the transaction at $0.81 per share. On Feb 18 ’25, another insider, Shaff Eric D., who serves as the CEO and President of the company, sold 12,726 shares for $0.81 each. As a result, the insider received 10,314 and left with 192,039 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 118355584 and an Enterprise Value of 149446224. For the stock, the TTM Price-to-Sale (P/S) ratio is 2011.54 while its Price-to-Book (P/B) ratio in mrq is 4.93. Its current Enterprise Value per Revenue stands at 1.183 whereas that against EBITDA is -4.108.
Stock Price History:
The Beta on a monthly basis for MCRB is 2.51, which has changed by -0.089356124 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, MCRB has reached a high of $1.53, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -13.69%, while the 200-Day Moving Average is calculated to be -20.92%.
Shares Statistics:
Over the past 3-months, MCRB traded about 1.51M shares per day on average, while over the past 10 days, MCRB traded about 781350 shares per day. A total of 170.20M shares are outstanding, with a floating share count of 127.27M. Insiders hold about 26.90% of the company’s shares, while institutions hold 22.97% stake in the company. Shares short for MCRB as of 1740700800 were 17234746 with a Short Ratio of 11.41, compared to 1738281600 on 17456803. Therefore, it implies a Short% of Shares Outstanding of 17234746 and a Short% of Float of 13.51.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
